Drug recall · November 25, 2015
RIFAMPIN FOR INJECTION USP recall
Why: Failed Impurity/Degradation Specifications: Out of Specifications result obtained for a known impurity.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
RIFAMPIN FOR INJECTION USP, 600 mg*/vial, Rx Only. Mfd. for: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-151-42.
- Lots / codes
Lot #: 14RIF1(A), Expiry: 9/30/2016.
- Quantity
- 6861 Vials
- Company
- Akorn, Inc., Lake Forest, IL
- Distribution
- US: Nationwide
- Initiated
- August 20, 2015 · Voluntary: Firm initiated
- Classified
- November 13, 2015
- Reported
- November 25, 2015
- Ended
- January 26, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Rifampin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.